Abstract:Abstract Background Severe asthma is a chronic disease contributing to disproportionate disease morbidity and mortality. From the year of 2007, many genome-wide association studies (GWAS) have documented a large number of asthma-associated genetic variants and related genes. Nevertheless, the molecular mechanism of these identified variants involved in asthma or severe asthma risk remains largely unknown. Methods In the current study, we systematically integrated 3 independent expression quantitative trait loci (eQTL) data ( N = 1977) and a large-scale GWAS summary data of moderate-to-severe asthma ( N = 30,810) by using the Sherlock Bayesian analysis to identify whether expression-related variants contribute risk to severe asthma. Furthermore, we performed various bioinformatics analyses, including pathway enrichment analysis, PPI network enrichment analysis, in silico permutation analysis, DEG analysis and co-expression analysis, to prioritize important genes associated with severe asthma. Results In the discovery stage, we identified 1129 significant genes associated with moderate-to-severe asthma by using the Sherlock Bayesian analysis. Two hundred twenty-eight genes were prominently replicated by using MAGMA gene-based analysis. These 228 replicated genes were enriched in 17 biological pathways including antigen processing and presentation (Corrected P = 4.30 × 10 − 6 ), type I diabetes mellitus (Corrected P = 7.09 × 10 − 5 ), and asthma (Corrected P = 1.72 × 10 − 3 ). With the use of a series of bioinformatics analyses, we highlighted 11 important genes such as GNGT2 , TLR6 , and TTC19 as authentic risk genes associated with moderate-to-severe/severe asthma. With respect to GNGT2 , there were 3 eSNPs of rs17637472 (P eQTL = 2.98 × 10 − 8 and P GWAS = 3.40 × 10 − 8 ), rs11265180 (P eQTL = 6.0 × 10 − 6 and P GWAS = 1.99 × 10 − 3 ), and rs1867087 (P eQTL = 1.0 × 10 − 4 and P GWAS = 1.84 × 10 − 5 ) identified. In addition, GNGT2 is significantly expressed in severe asthma compared with mild-moderate asthma ( P = 0.045), and Gngt2 shows significantly distinct expression patterns between vehicle and various glucocorticoids (Anova P = 1.55 × 10 − 6 ). Conclusions Our current study provides multiple lines of evidence to support that these 11 identified genes as important candidates implicated in the pathogenesis of severe asthma.

Machine Learning and Bioinformatics Approaches to Identify the Candidate Biomarkers in Severe Asthma

Identification and validation of three potential biomarkers and immune microenvironment for in severe asthma in microarray and single-cell datasets

Assessing prospective molecular biomarkers and functional pathways in severe asthma based on a machine learning method and bioinformatics analyses

Identification of candidate genes and molecular mechanisms related to asthma progression using bioinformatics

Identification of key genes and pathways between mild-moderate and severe asthmatics via bioinformatics analysis

Identification of TXN and F5 as novel diagnostic gene biomarkers of the severe asthma based on bioinformatics and machine learning analysis

Deciphering the Immune Subtypes and Signature Genes: A Novel Approach Towards Diagnosing and Prognosticating Severe Asthma through Interpretable Machine Learning

Identification of biomarkers and pathogenesis in severe asthma by coexpression network analysis

Consistent Biomarkers And Related Pathogenesis Underlying Asthma Revealed By Systems Biology Approach

Identification of Potential Transcriptomic Markers in Developing Asthma: an Integrative Analysis of Gene Expression Profiles

m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma

Bronchial epithelial transcriptomics and experimental validation reveal asthma severity-related neutrophilc signatures and potential treatments

The Early Detection of Asthma Based on Blood Gene Expression

Identification of shared potential diagnostic markers in asthma and depression through bioinformatics analysis and machine learning

Biomarkers associated with disease severity in allergic and nonallergic asthma

The Transcriptome Characteristics of Severe Asthma From the Prospect of Co-Expressed Gene Modules

Integrated genomics analysis highlights important SNPs and genes implicated in moderate-to-severe asthma based on GWAS and eQTL datasets

Pulmonary Microrna Profiles Identify Involvement of Creb1 and Sec14l3 in Bronchial Epithelial Changes in Allergic Asthma

MBD2 as a Potential Novel Biomarker for Identifying Severe Asthma With Different Endotypes

Single-cell transcriptomic analysis reveals key immune cell phenotypes in the lungs of patients with asthma exacerbation

CDC167 exhibits potential as a biomarker for airway inflammation in asthma